WS #16499
Caterpillar reported a 17% year-over-year revenue jump to $20.7 billion with EPS of $7.20, signaling sustained demand in power and energy segments. Merck topped estimates with $2.49 EPS, driven by Keytruda strength, and raised its profit outlook. These results provide a defensive anchor in a volatile session, highlighting specific corporate resilience against broader geopolitical headwinds.
Pharma & Industrial Earnings Beats
Caterpillar reported a 17% year-over-year revenue jump to $20.7 billion with EPS of $7.20, signaling sustained demand in power and energy segments. Merck topped estimates with $2.49 EPS, driven by Keytruda strength, and raised its profit outlook. These results provide a defensive anchor in a volatile session, highlighting specific corporate resilience against broader geopolitical headwinds.